Skip to main content

Table 2 Relationship between CSMD1 expression and clinical features of patients with hepatocellular carcinoma

From: Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis

Wk13374861variables CSMD1-positive CSMD1-negative χ 2 P
Age (years)     
  ≤ 52 (n = 68) 19 49 0.026 0.872
  > 52 (n = 60) 16 44   
Sex     
 Male (n = 108) 29 79 0.084 0.772
 Female (n = 20) 6 14   
AFP     
  ≥ 20 ng/mL (n = 76) 21 55 0.008 0.930
  < 20 ng/mL (n = 52) 14 38   
HBsAg or HCV     
  + (n = 86) 24 62 0.042 0.838
 - (n = 42) 11 31   
HCC differentiation     
 Grade I (n = 14) 6 8 2.856 0.240
 Grade II (n = 78) 22 56   
 Grade III (n = 36) 7 29   
Tumor size     
  ≥ 5 cm (n = 68) 20 48 0.312 0.576
  < 5 cm (n = 60) 15 45   
Extrahepatic metastasis     
 Presence (n = 42) 11 31 0.042 0.838
 Absence (n = 86) 24 62